InvestorsHub Logo

Smilin_B

11/27/18 11:53 AM

#86095 RE: gumzsa #86094

EDGE shareholders retain only a 30% interest in the reversed merged entity. That could be the disappointng reason. EDGE has been trading at their remaining cash on hand level since their clinical study failed.